地拉罗司-三价铁络合物的电荷状态。 - Suppr

Suppr

超能文献

Charge states of deferasirox-ferric iron complexes.

作者信息

Hider Robert C

出版信息

Am J Kidney Dis. 2010 Mar;55(3):614-5. doi: 10.1053/j.ajkd.2009.10.065.

DOI:10.1053/j.ajkd.2009.10.065

PMID:20189051

Abstract

摘要

相似文献

Charge states of deferasirox-ferric iron complexes.

Am J Kidney Dis. 2010 Mar;55(3):614-5. doi: 10.1053/j.ajkd.2009.10.065.

Fanconi syndrome due to deferasirox.

Am J Kidney Dis. 2009 Nov;54(5):931-4. doi: 10.1053/j.ajkd.2009.03.013. Epub 2009 Jun 3.

Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire.

J Pediatr Hematol Oncol. 2010 Oct;32(7):525-6. doi: 10.1097/MPH.0b013e3181ec0c4d.

Acute renal failure and Fanconi syndrome due to deferasirox.

Nephrol Dial Transplant. 2010 Jul;25(7):2376-8. doi: 10.1093/ndt/gfq224. Epub 2010 Apr 20.

Reversible Fanconi syndrome in a pediatric patient on deferasirox.

Pediatr Blood Cancer. 2011 Apr;56(4):674-6. doi: 10.1002/pbc.22711. Epub 2010 Dec 6.

A case report of deferasirox-induced kidney injury and Fanconi syndrome.

WMJ. 2013 Aug;112(4):177-80.

Acquired proximal renal tubular dysfunction in β-thalassemia patients treated with deferasirox.

J Pediatr Hematol Oncol. 2010 Oct;32(7):564-7. doi: 10.1097/MPH.0b013e3181ec0c38.

Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.

Nephrology (Carlton). 2015 Dec;20(12):931-5. doi: 10.1111/nep.12523.

Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia.

Br J Haematol. 2014 Nov;167(3):434-6. doi: 10.1111/bjh.13002. Epub 2014 Jul 2.

Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state.

Drug Metab Dispos. 2010 May;38(5):808-16. doi: 10.1124/dmd.109.030833. Epub 2010 Jan 22.

引用本文的文献

Iron Chelators in Treatment of Iron Overload.

J Toxicol. 2022 May 5;2022:4911205. doi: 10.1155/2022/4911205. eCollection 2022.

A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions.

PLoS One. 2015 Jul 20;10(7):e0133050. doi: 10.1371/journal.pone.0133050. eCollection 2015.

Deferasirox nephrotoxicity-the knowns and unknowns.

Nat Rev Nephrol. 2014 Oct;10(10):574-86. doi: 10.1038/nrneph.2014.121. Epub 2014 Jul 22.

Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire.

J Pediatr Hematol Oncol. 2010 Oct;32(7):525-6. doi: 10.1097/MPH.0b013e3181ec0c4d.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Charge states of deferasirox-ferric iron complexes.

Am J Kidney Dis. 2010 Mar;55(3):614-5. doi: 10.1053/j.ajkd.2009.10.065.

Fanconi syndrome due to deferasirox.

Am J Kidney Dis. 2009 Nov;54(5):931-4. doi: 10.1053/j.ajkd.2009.03.013. Epub 2009 Jun 3.

Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire.

J Pediatr Hematol Oncol. 2010 Oct;32(7):525-6. doi: 10.1097/MPH.0b013e3181ec0c4d.

Acute renal failure and Fanconi syndrome due to deferasirox.

Nephrol Dial Transplant. 2010 Jul;25(7):2376-8. doi: 10.1093/ndt/gfq224. Epub 2010 Apr 20.

Reversible Fanconi syndrome in a pediatric patient on deferasirox.

Pediatr Blood Cancer. 2011 Apr;56(4):674-6. doi: 10.1002/pbc.22711. Epub 2010 Dec 6.

A case report of deferasirox-induced kidney injury and Fanconi syndrome.

WMJ. 2013 Aug;112(4):177-80.

Acquired proximal renal tubular dysfunction in β-thalassemia patients treated with deferasirox.

J Pediatr Hematol Oncol. 2010 Oct;32(7):564-7. doi: 10.1097/MPH.0b013e3181ec0c38.

Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.

Nephrology (Carlton). 2015 Dec;20(12):931-5. doi: 10.1111/nep.12523.

Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia.

Br J Haematol. 2014 Nov;167(3):434-6. doi: 10.1111/bjh.13002. Epub 2014 Jul 2.

Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state.

Drug Metab Dispos. 2010 May;38(5):808-16. doi: 10.1124/dmd.109.030833. Epub 2010 Jan 22.

引用本文的文献

Iron Chelators in Treatment of Iron Overload.

J Toxicol. 2022 May 5;2022:4911205. doi: 10.1155/2022/4911205. eCollection 2022.

A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions.

PLoS One. 2015 Jul 20;10(7):e0133050. doi: 10.1371/journal.pone.0133050. eCollection 2015.

Deferasirox nephrotoxicity-the knowns and unknowns.

Nat Rev Nephrol. 2014 Oct;10(10):574-86. doi: 10.1038/nrneph.2014.121. Epub 2014 Jul 22.

Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire.

J Pediatr Hematol Oncol. 2010 Oct;32(7):525-6. doi: 10.1097/MPH.0b013e3181ec0c4d.